We have located links that may give you full text access.
Minibeam radiotherapy with small animal irradiators; <i>in-vitro</i> and <i>in-vivo</i> feasibility studies.
Physics in Medicine and Biology 2017 October 11
Minibeam radiation therapy (MBRT) delivers ultrahigh dose of X-ray (≥100 Gy) in 200-1000 μm beams (peaks), separated by wider non-irradiated regions (valleys) usually as a single temporal fraction. Preclinical studies performed at synchrotron facilities revealed that MBRT is able to ablate tumors while maintaining normal tissue integrity. The main purpose of present study was to develop an efficient and accessible method to perform MBRT using a conventional X-ray irradiator. We then tested this new method both in-vitro and in-vivo. Using commercially available lead ribbon and polyethylene sheets, we constructed a collimator that converts the cone beam of an industrial irradiator to 44 identical beams (Collimator size ≈ 4×10 cm). The dosimetry characteristics of the generated beams were evaluated using two different radiochromic films (beam FWHM = 246±32 μm; center-to-center = 926±23 μm; peak-to-valley dose ratio = 24.35±2.10; collimator relative output factor = 0.84±0.04). Clonogenic assays demonstrated the ability of our method to induce radiobiological cell death in two radioresistant murine tumor cell lines (TRP = glioblastoma; B16-F10 = melanoma). Radiobiological equivalent dose (RBE) was calculated by evaluating the acute skin response to graded doses of MBRT and conventional radiotherapy (CRT). The normal mouse skin demonstrated resistance to doses up to 150 Gy on peak. MBRT significantly extended the survival of mice with flank melanoma tumor compared to CRT when RBE were applied (overall p<.001). Loss of spatial resolution deep in the tissue has been a major concern. The beams generated using our collimator maintained their resolution in-vivo (mouse brain tissue) and up to 10cm deep in the radiochromic film. In conclusion, the initial dosimetric, in-vitro and in-vivo evaluations confirmed the utility of this affordable and easy-to-replicate minibeam collimator for future preclinical studies.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app